← ANALYST RATINGS · TIPRANKS

Metlife (MET): analyst forecast and price target

$101 +0.49% close 16.10.26 · market cap $63.4B · Financial · Insurance - Life SPY 0.08%
Price targets and ratings of

Analyst consensus

Strong Buy

10 Buy1 Hold0 Sell

Ratings of 11 analysts in the last 3 months · top analysts only

12-month forecast

$111+10.4% upside

Based on 11 price targets given in the last 3 months, the average target is $111, the highest $119, the lowest $108. The average is +10.4% from the last price of $101.

$80.00$100$120Jan 26AprJulOctJan 27AprJulOctHigh$119Average$111Low$108
Highest target $119 Average target $111 Lowest target $108
AnalystFirmPrice target RatingUpsideAction Date Move vs SPY
Pablo Singzon★★★★★★★★★★#2864 · hits 60% · avg +9.5% J.P. Morgan $108 → $110+1.9% Buy +9.2% Assigned 15.10.26on TipRanks 07:40 +0.3%next day +1.6%
Wesley Carmichael★★★★★★★★★★#2704 · hits 73% · avg +17.5% Wells Fargo $109 → $110+0.9% Buy +9.2% Reiterated 12.10.26on TipRanks 08:50 +1.9%next day +0.5%
Paul Newsome★★★★★★★★★★#122 · hits 73% · avg +13.9% Piper Sandler $110 Buy +9.2% Reiterated 12.10.26on TipRanks 06:55 +1.9%next day +0.5%
Joshua Shanker★★★★★★★★★★#1027 · hits 61% · avg +7.2% Bank of America Securities $119 Buy +18.1% Reiterated 12.10.26on TipRanks 06:15 +1.9%next day +0.5%
Ryan Krueger★★★★★★★★★★#560 · hits 72% · avg +13.6% KBW $108 Buy +7.2% Reiterated 08.10.26on TipRanks 16:50 −0.7%next day +1.9% · 5 days +4.4%
Yaron Kinar★★★★★★★★★★#401 · hits 72% · avg +12.2% Mizuho Securities $112 → $109−2.7% Buy +8.2% Reiterated 07.10.26on TipRanks 07:20 −1.2%next day +3.2% · 5 days +5.1%
Alex Scott★★★★★★★★★★#1272 · hits 60% · avg +7.0% Barclays $97.00 → $111+14.4% Buy +10.2% Reiterated 07.10.26on TipRanks 03:55 −1.2%next day +3.2% · 5 days +5.1%
Michael Ward CFA★★★★★★★★★★#1129 · hits 71% · avg +13.8% UBS $105 → $110+4.8% Buy +9.2% Reiterated 06.10.26on TipRanks 07:35 −0.3%next day −1.2% · 5 days +3.7%
Bob Huang★★★★★★★★★★#6914 · hits 57% · avg +0.4% Morgan Stanley $111 Buy +10.2% Assigned 05.10.26on TipRanks 08:35 +1.9%next day −0.3% · 5 days +3.0%
Andrew Kligerman★★★★★★★★★★#731 · hits 68% · avg +11.3% TD Cowen $105 → $110+4.8% Buy +9.2% Assigned 05.10.26on TipRanks 07:31 +1.9%next day −0.3% · 5 days +3.0%
Michael Ward CFA★★★★★★★★★★#1129 · hits 71% · avg +13.8% UBS $105 Buy +4.2% Assigned 02.10.26on TipRanks 10:15 −0.7%next day +1.9% · 5 days +3.0%
Suneet Kamath★★★★★★★★★★#644 · hits 68% · avg +10.5% Jefferies $103 → $115+11.7% Buy +14.1% Reiterated 01.10.26on TipRanks 10:25 0.0%next day −0.7% · 5 days +3.1%
Wilma Burdis★★★★★★★★★★#2846 · hits 77% · avg +10.4% Raymond James — Hold — Reiterated 29.09.26on TipRanks 09:11 −0.5%next day −0.9% · 5 days +0.1%
Paul Newsome★★★★★★★★★★#122 · hits 73% · avg +13.9% Piper Sandler $110 Buy +9.2% Upgrade 25.09.26on TipRanks Sep 22 05:00 −0.7%next day +2.1% · 5 days +0.4%
Bob Huang★★★★★★★★★★#6914 · hits 57% · avg +0.4% Morgan Stanley $103 → $111+7.8% Buy +10.2% Assigned 24.08.26on TipRanks 08:15 +2.3%next day −0.7% · 5 days −1.5%
Wesley Carmichael★★★★★★★★★★#2704 · hits 73% · avg +17.5% Wells Fargo $101 → $109+7.9% Buy +8.2% Reiterated 19.08.26on TipRanks 04:50 −1.9%next day −0.9% · 5 days +1.9%
Yaron Kinar★★★★★★★★★★#401 · hits 72% · avg +12.2% Mizuho Securities $102 → $112+9.8% Buy +11.2% Reiterated 11.08.26on TipRanks Aug 12 08:15 +0.1%next day −0.4% · 5 days +0.3%
Pablo Singzon★★★★★★★★★★#2864 · hits 60% · avg +9.5% J.P. Morgan $106 → $108+1.9% Buy +7.2% Reiterated 11.08.26on TipRanks 07:35 +0.1%next day −0.4% · 5 days +0.3%
Ryan Krueger★★★★★★★★★★#560 · hits 72% · avg +13.6% KBW $105 → $108+2.9% Buy +7.2% Reiterated 11.08.26on TipRanks 04:55 +0.1%next day −0.4% · 5 days +0.3%
Alex Scott★★★★★★★★★★#1272 · hits 60% · avg +7.0% Barclays $94.00 → $97.00+3.2% Buy −3.7% Reiterated 06.08.26on TipRanks 04:16 +4.0%next day −2.8% · 5 days −3.7%
Joshua Shanker★★★★★★★★★★#1027 · hits 61% · avg +7.2% Bank of America Securities $103 → $119+15.5% Buy +18.1% Reiterated 05.08.26on TipRanks Aug 6 04:50 +0.3%next day +4.0% · 5 days +0.1%
Andrew Kligerman★★★★★★★★★★#731 · hits 68% · avg +11.3% TD Cowen $87.00 → $105+20.7% Buy +4.2% Reiterated 22.07.26on TipRanks Jul 23 21:15 0.0%next day +0.5% · 5 days +6.4%
Suneet Kamath★★★★★★★★★★#644 · hits 68% · avg +10.5% Jefferies $103 Buy +2.2% Reiterated 09.07.26on TipRanks Jul 10 07:56 +0.3%next day +0.1% · 5 days +2.9%
Michael Ward CFA★★★★★★★★★★#1129 · hits 71% · avg +13.8% UBS $102 → $105+2.9% Buy +4.2% Assigned 08.07.26on TipRanks 06:55 −1.4%next day +0.3% · 5 days +1.1%
Thomas Gallagher★★★★★★★★★★#2492 · hits 61% · avg +7.2% Evercore ISI $95.00 → $96.00+1.1% Hold −4.7% Reiterated 09.04.26on TipRanks 08:40 −0.2%next day −1.0% · 5 days +0.1%
Kevin Heal★★★★★★★★★★#879 · hits 74% · avg +12.6% Argus Research $90.00 Buy −10.7% Reiterated 08.12.25on TipRanks Dec 9 10:00 −0.4%next day −0.2% · 5 days +6.2%

Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst

Best analysts covering Metlife

TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.

Most accurate

3 months Ryan Krueger★★★★★★★★★★KBW · #560
Hits 72%163 of 226 Average return +13.6%
1 year Ryan Krueger★★★★★★★★★★KBW · #560
Hits 72%163 of 226 Average return +13.6%
2 years Alex Scott★★★★★★★★★★Barclays · #1272
Hits 60%249 of 414 Average return +7.0%

Most profitable

3 months Ryan Krueger★★★★★★★★★★KBW · #560
Hits 72%163 of 226 Average return +13.6%
1 year Ryan Krueger★★★★★★★★★★KBW · #560
Hits 72%163 of 226 Average return +13.6%
2 years Andrew Kligerman★★★★★★★★★★TD Cowen · #731
Hits 68%181 of 267 Average return +11.3%

How the average price target moved

The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $109 at a price of $94.16 (+15.8%); now: $111 at $101 (+10.3%).

$95.00$100$105$110Sep 15Oct 1Oct 15Top analysts$111Average target$111Price$101

PriceAverage targetTop analysts’ target

Recommendation trend · top analysts

01020201Oct 25101Nov131Dec152Jan 26174Feb163Mar154Apr165May136Jun174Jul172Aug182Sep192Oct

Strong BuyBuyHoldSell

Rating05.2606.2607.2608.2609.2610.26
Strong Buy000000
Buy161317171819
Hold564222
Sell000000

Earnings and sales forecast

Next report: 04.11.26 (Q3 2026, date not confirmed)

Earnings per share

Next quarter’s EPS estimate — $2.76 (from $2.55 to $2.91). Last quarter: $2.43.

Sales

Next quarter’s sales estimate — $19.9B (from $19.2B to $20.6B). Last quarter: $19.3B.

Best top-analyst consensus in the sector · Financial

SSBSouthState Corporation
SPGIS&P Global
PLMRPalomar Holdings
SEICSEI Investments Company
RIOTRiot Platforms
About Metlife
  • CEO: Michel Abbas Khalaf
  • Employees: 46,000
  • 200 Park Avenue, New York City, NY, 10166-0188, US
  • www.metlife.com

MetLife, Inc. operates as a leading global financial services entity, delivering an extensive array of services encompassing insurance, annuities, employee benefits, and asset management. The company manages its operations through five primary divisions: the U.S., Asia, Latin America, Europe, the Middle East and Africa (EMEA), and MetLife Holdings. Its broad insurance offerings include life, dental, group short-term and long-term disability, individual disability, pet, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans. MetLife also supports employers with administrative services-only (ASO) arrangements. Furthermore, it provides sophisticated financial instruments such as general and separate account contracts, synthetic guaranteed interest contracts, and private floating rate funding agreements. The company facilitates pension risk transfers, offers institutional income annuities, structures settlements, and delivers capital markets investment products. Specialized life insurance products and funding agreements are also available for post-retirement benefits, alongside company, bank, or trust-owned life insurance used to finance non-qualified executive benefit programs. In addition, MetLife offers a variety of annuity options including fixed, indexed-linked, and variable, alongside pension and regular savings products. Its life insurance portfolio features whole life, term life, endowments, universal and variable life, and group life policies. The company also provides longevity reinsurance solutions, credit insurance products, and protection for long-term healthcare services. MetLife, Inc. was founded in 1863 and is headquartered in New York City.

Data from the stock’s TipRanks forecast page, read 32 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗